Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levilimab in Rheumatoid Arthritis (LUNAR)
NCT05800327Phase 3Active, not recruiting
- Sponsor
- BIOCAD
- Start
- Dec 2022
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of levilimab in rheumatoid arthritis (RA), sponsored by BIOCAD. Started Dec 2022; status: active, not recruiting.
02
Drugs
levilimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05800327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05800327.